- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06014684
Timing Exercise Training as Strategy to Improve Insulin Sensitivity and Substrate Metabolism in Men and Woman With Pre-diabetes (Timed Training)
n a retrospective analysis of an exercise training program performed either in the morning or afternoon, we found that the afternoon training group improved their peripheral insulin sensitivity and fasting plasma glucose levels to a greater extent than the morning group. However, underlying mechanisms are unclear.
The main objective of this study is to determine whether prolonged exercise training in the afternoon (15:00-17:00 PM) differs from exercise training in the morning (07:00-09:00 AM) in improving insulin sensitivity in individuals with pre-diabetes, and to investigate its underlying mechanisms.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Rationale: Various metabolic processes, including resting metabolic rate, insulin sensitivity and insulin secretion, follow a recurring 24-hour cycle. These rhythms are shown to be disturbed in in pre-diabetes volunteers compared to young healthy volunteers. In a retrospective analysis of an exercise training program performed either in the morning or afternoon, we found that the afternoon training group improved their peripheral insulin sensitivity and fasting plasma glucose levels to a greater extent than the morning group. However, underlying mechanisms are unclear.
Objective: The main objective of this study is to determine whether prolonged exercise training in the afternoon (15:00-17:00 PM) differs from exercise training in the morning (07:00-09:00 AM) in improving insulin sensitivity in individuals with pre-diabetes, and to investigate its underlying mechanisms.
Study design: The present study is a randomized double arm longitudinal intervention study in a pre and post design.
Study population: 24 pre-diabetic individuals (men and postmenopausal women aged 40 - 75 years and with BMI ≥ 25 and ≤ 38 kg/m2) will complete this study (12 participants in the morning training group and 12 participants in the afternoon training group). From experience with similar studies, we estimate a drop-out rate of 20% and a screening failure of 70% (because individuals often do not know they are pre-diabetic). This results in maximally 30 participants that have to be included and 100 participants that have to be screened (maximally).
Intervention (if applicable): Participants will perform a 12-weeks supervised high intensity interval training (HIIT) program with three ~30 min exercise sessions per week. Participants will be randomly assigned to the morning or afternoon training time. To assess the outcomes, participants will come to the university for a 43h measurement period both before and after the 12-week training program.
Main study parameters/endpoints: The primary study endpoint is peripheral insulin sensitivity measured via a 2-step hyperinsulinemic-euglycemic clamp. The secondary outcomes are 24h energy and substrate metabolism. Exploratory outcomes are body composition, intrahepatic lipid content and composition, hepatic insulin sensitivity, hepatic glycogen levels, maximal aerobic capacity, skeletal muscle oxidative capacity, visceral and subcutaneous adipose tissue volume, sleeping metabolic rate, blood glucose levels (continuously measured over 7days) and immune responses.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Ivo Habets, MSc
- Phone Number: +31 88 388 7287
- Email: i.habets@maastrichtuniversity.nl
Study Contact Backup
- Name: Soraya de Kam, MSc
- Email: soraya.dekam@maastrichtuniversity.nl
Study Locations
-
-
Limburg
-
Maastricht, Limburg, Netherlands, 6229 ER
- Recruiting
- Maastricht University
-
Contact:
- Ivo Habets, MSc
- Phone Number: +31 88 388 7287
- Email: i.habets@maastrichtuniversity.nl
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Aged 40-75 years.
- Body mass index (BMI) ≥25 kg/m2
- Male, or postmenopausal (at least 1 year post cessation of menses) female
Pre-diabetes based on one or a combination of the following criteria:
- Impaired Glucose Tolerance (IGT): plasma glucose values ≥ 7.8 mmol/l and ≤ 11.1 mmol/l 120 minutes after glucose drink consumption during OGTT in screening
- ImpairedFastingGlucose(IFG):Fastingplasmaglucose≥6.1mmol/land≤6.9 mmol/l
- Insulin Resistance: glucose clearance rate ≤ 360 mL/kg/min, as determined during the OGTT using OGIS120.
- HbA1cof5.7-6.4%
Exclusion Criteria:
- Type 2 diabetes
- Patients with active congestive heart failure and and/or severe renal and or liver insufficiency
- Uncontrolled hypertension
- Any contra-indication for MRI scanning
- Alcohol consumption of >3 servings per day for man and >2 servings per day for woman
- Smoking
- Unstable body weight (weight gain or loss > 5kg in the last 3 months)
- Previous enrolment in a clinical study with an investigational product during the last 3 months or as judged by the Investigator which would possibly hamper our study results.
- Medication use known to hamper subject's safety during the study procedures.
- Subjects who do not want to be informed about unexpected medical findings.
- Men: Hb <8.0 mmol/L, Women: Hb <7.0 mmol/l
- Heavily varying sleep-wake rhythm (i.e. night shift work and travels across time zones).
- Significant food allergies/intolerance (seriously hampering study meals)
- Blood donation during or within 2 months prior to the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: AM exercise
HIIT program performed between 07:00-09:00 AM
|
High Intensity Interval Training (HIIT) program for 12 weeks (3 per week/36 sessions in total)
|
Experimental: PM exercise
HIIT program performed between 15:00-17:00 PM
|
High Intensity Interval Training (HIIT) program for 12 weeks (3 per week/36 sessions in total)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Peripheral Insulin sensitivity
Time Frame: measured before and after the 12 weeks training program
|
Glucose disposal rate under high insulin concentrations during the second step of the 2-step hyperinsulinemic-euglycemic clamp.
|
measured before and after the 12 weeks training program
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
24h whole body energy expenditure
Time Frame: measured before and after the 12 weeks training program
|
energy expenditure as measured by a 24h stay in the respiration chamber
|
measured before and after the 12 weeks training program
|
24h substrate metabolism
Time Frame: measured before and after the 12 weeks training program
|
24h substrate metabolism as measured by a 24h stay in the respiration chamber
|
measured before and after the 12 weeks training program
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Body composition by Dual Energy X-ray Absorptiometry (DEXA)
Time Frame: measured before and after the 12 weeks training program
|
fat-free mass (kg and percentage)
|
measured before and after the 12 weeks training program
|
Body composition by Dual Energy X-ray Absorptiometry (DEXA)
Time Frame: measured before and after the 12 weeks training program
|
fat mass (kg and percentage)
|
measured before and after the 12 weeks training program
|
Intrahepatic lipid content and composition
Time Frame: measured before and after the 12 weeks training program
|
measured before and after the 12 weeks training program
|
|
Hepatic glycogen levels
Time Frame: measured before and after the 12 weeks training program
|
measured before and after the 12 weeks training program
|
|
VO2 max cycling test
Time Frame: measured before and after the 12 weeks training program
|
measurement of participants' maximal aerobic capacity, absolute (L/min) and relative (ml/min/kg)
|
measured before and after the 12 weeks training program
|
Skeletal muscle oxidative capacity
Time Frame: measured before and after the 12 weeks training program
|
Ex vivo high-resolution respirometry using a two chamber Oxygraph (OROBOROS Instruments) will be performed.
Multiple substrate/inhibitor titration protocols will be applied to extensively characterize the mitochondrial capacity of skeletal muscle fibers
|
measured before and after the 12 weeks training program
|
Sleeping metabolic rate
Time Frame: measured before and after the 12 weeks training program
|
measured before and after the 12 weeks training program
|
|
Blood glucose levels measured continuously over 7 days.
Time Frame: measured before and at the end the 12 weeks training program
|
measured before and at the end the 12 weeks training program
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NL83421.068.22
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overweight and Obesity
-
University Hospital, LilleNational Research Agency, France; European Union; University of Lille Nord de... and other collaboratorsNot yet recruitingOverweight and Obesity | Overweight, Childhood | Overweight, Infant
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Institut Investigacio Sanitaria Pere VirgiliCompletedObesity, Childhood | Overweight and Obesity | Overweight, ChildhoodSpain
-
Memorial Sloan Kettering Cancer CenterRecruitingObesity | Overweight | Overweight and Obesity | Obese | Overweight or ObesityUnited States
-
Holbaek SygehusUniversity of Copenhagen; University of Florida; University of Minnesota; Hebrew... and other collaboratorsRecruitingChildhood Overweight and ObesityDenmark
-
Universidade do Extremo Sul Catarinense - Unidade...RecruitingObesity | Overweight and Obesity | Obesity; Endocrine | Overweight, Obesity and Other HyperalimentationBrazil
-
Mexican National Institute of Public HealthUNICEFCompleted
-
Universidade do PortoFundação para a Ciência e a Tecnologia; Administração Regional de Saúde do... and other collaboratorsCompletedOverweight and ObesityPortugal
-
University of British ColumbiaTerminatedOverweight and ObesityCanada
-
National Taiwan University HospitalCompleted
Clinical Trials on Timing of exercise
-
Maastricht UniversityRecruiting
-
Université de MontréalUnknownEnergy IntakeCanada
-
University of UtahRecruitingDiabetes Mellitus, Type 2 | Insulin Resistance | Glucose Intolerance | Sleep Disturbance | Overweight or Obesity | Insulin SensitivityUnited States
-
Rigshospitalet, DenmarkRecruitingEndocarditis, BacterialDenmark
-
Colorado Center for Reproductive MedicineFertility Laboratories Of ColoradoTerminatedInfertility | Embryonic Development | Fertilization in VitroUnited States
-
University of Mississippi Medical CenterWithdrawnCerebrovascular Disorders | Neuromuscular Diseases | Spinal Cord Injuries | Neurologic Injury | Stroke, Acute | Coma | Status Epilepticus | Neurological Injury | TBIUnited States
-
All India Institute of Medical Sciences, New DelhiUnknown
-
University of Texas at AustinNot yet recruitingTraumatic Intracranial Hemorrhage